High dose Recombinant Herpes Zoster Vaccine (CHO cells)

BIOLOGICAL2 trials

Sponsors

MAXVAX Biotechnology Limited Liability Company

Conditions

Herpes Zoster

Phase 1

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Active, not recruitingNCT05636436

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2022-12-07End: 2024-12-30Updated: 2024-11-20

Phase 2

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Active, not recruitingNCT05856084

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2023-05-07End: 2026-03-31Target: 924Updated: 2024-11-20